Not sure about subscribing? Every plan starts with a free 2-day trial—try it out, and cancel anytime before billing.
Learn more
Answered on: N/A. Time taken: N/A.
Retry question

Last Mile

Case Interview Practice > 
Math

RapidShift is modeling what a residential last-mile entry would look like in one pilot city. The team estimates 800 deliveries per day at an average revenue of $12 per delivery. Variable costs are estimated at $9 per delivery and fixed costs for the pilot would run $40,000 per month. Assume 25 operating days per month. Is the pilot profitable on a monthly basis, and what is the breakeven number of daily deliveries?

Case Exhibit

Your Response
Whoops... look like you haven't answered this question yet.
Sample answer from an expert consultant

Rounding is standard practice in case interviews and almost always permitted with a quick ask.

Step 1: Calculate monthly revenue

800 deliveries per day x 25 days = 20,000 deliveries per month. 20,000 x $12 = $240,000 monthly revenue

Step 2: Calculate monthly variable costs

20,000 deliveries x $9 = $180,000 monthly variable costs

Step 3: Calculate monthly contribution and profit

Contribution: $240,000 - $180,000 = $60,000. Less fixed costs: $60,000 - $40,000 = $20,000 monthly profit

The pilot is profitable at 800 deliveries per day.

Step 4: Calculate breakeven daily deliveries

Contribution margin per delivery: $12 - $9 = $3. Monthly fixed costs: $40,000. Breakeven deliveries per month: $40,000 / $3 = 13,333 deliveries per month. Breakeven per day: 13,333 / 25 = 533 deliveries per day

Rounded: ~535 deliveries per day to break even.

Step 5: Contextualize

At 800 deliveries per day the pilot runs at a 50% cushion above breakeven, which is a reasonable buffer. However the $3 contribution margin per delivery is thin. Any increase in variable costs, such as fuel prices, failed delivery rates, or driver wages, could erode profitability quickly. This reinforces the earlier observation that residential last-mile is a volume and density game, and unit economics need to be stress-tested carefully before committing to a broader rollout.

31-3